GI02-38
A Phase II Study of Capecitabine plus Docetaxel Combination in Patients with Esophageal/Gastric Cancer
A Phase II Study of Capecitabine plus Docetaxel Combination in Patients with Esophageal/Gastric Cancer
© 2024 Hoosier Cancer Research Network | 7676 Interactive Way, Suite 120 · Indianapolis, IN 46278 | (317) 921-2050 | contact@hoosiercancer.org | Terms of Use | Privacy Policy | Sitemap
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter